A rating of 66 puts Avadel Pharmaceuticals PLC (AVDL) near the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Avadel Pharmaceuticals PLC's score of 66 means it scores higher than 66% of stocks in the industry. Avadel Pharmaceuticals PLC also received an overall rating of 35, putting it above 35% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 139 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Avadel Pharmaceuticals PLC Stock Today?
Avadel Pharmaceuticals PLC (AVDL) stock is lower by -2.64% while the S&P 500 has gained 1.11% as of 2:09 PM on Thursday, Sep 24. AVDL is down -$0.14 from the previous closing price of $5.23 on volume of 856,191 shares. Over the past year the S&P 500 has gained 9.65% while AVDL has gained 17.28%. AVDL earned $0.11 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 46.1.